CD69 and pachyonychia congenita: Although further study is required, these data suggest that NK cells upregulate activation and maturation markers but are rendered more responsive to immune checkpoint pathways during PC progression, corroborating a recent study of the characterization of PD-1+ NK cells co-expressing CD69 in mouse tumor models (47).